Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder—Preliminary Results of the PROVIT Study

Major depressive disorder (MDD) is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Probiotics have the potential to be well-tolerated and cost-efficient treatment options. However, the molecular pathways of their effects are not fully elucidated yet. Based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiter, Alexandra, Bengesser, Susanne A., Hauschild, Anne-Christin, Birkl-Töglhofer, Anna-Maria, Fellendorf, Frederike T., Platzer, Martina, Färber, Tanja, Seidl, Matthias, Mendel, Lilli-Marie, Unterweger, Renate, Lenger, Melanie, Mörkl, Sabrina, Dalkner, Nina, Birner, Armin, Queissner, Robert, Hamm, Carlo, Maget, Alexander, Pilz, Rene, Kohlhammer-Dohr, Alexandra, Wagner-Skacel, Jolana, Kreuzer, Kathrin, Schöggl, Helmut, Amberger-Otti, Daniela, Lahousen, Theresa, Leitner-Afschar, Birgitta, Haybäck, Johannes, Kapfhammer, Hans-Peter, Reininghaus, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551871/
https://www.ncbi.nlm.nih.gov/pubmed/32858844
http://dx.doi.org/10.3390/nu12092575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551871/
https://www.ncbi.nlm.nih.gov/pubmed/32858844
http://dx.doi.org/10.3390/nu12092575

Ejemplares similares